NBRV - Nabriva Therapeutics plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts5566
Avg. Estimate-0.29-0.31-1.39-1.15
Low Estimate-0.42-0.41-1.63-1.43
High Estimate-0.17-0.22-1.21-0.74
Year Ago EPS-0.79-0.61-2.49-1.39
Revenue EstimateCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
No. of Analysts6676
Avg. Estimate2.3M1.06M11.56M21.53M
Low Estimate1M500k10.22M13.27M
High Estimate7.07M1.9M16.32M30.4M
Year Ago Sales1.47M1.12M5.32M11.56M
Sales Growth (year/est)56.70%-5.50%117.30%86.20%
Earnings History9/29/201712/30/20173/30/20186/29/2018
EPS Est.-0.58-0.57-0.59-0.48
EPS Actual-0.79-0.61-0.36-0.44
Difference-0.21-0.040.230.04
Surprise %-36.20%-7.00%39.00%8.30%
EPS TrendCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.29-0.31-1.39-1.15
7 Days Ago-0.29-0.31-1.38-1.17
30 Days Ago-0.31-0.34-1.52-1.45
60 Days Ago-0.48-0.47-1.83-1.78
90 Days Ago-0.47-0.48-1.82-1.8
EPS RevisionsCurrent Qtr. (Sep 2018)Next Qtr. (Dec 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNBRVIndustrySectorS&P 500
Current Qtr.63.30%N/AN/A0.32
Next Qtr.49.20%N/AN/A0.43
Current Year44.20%N/AN/A0.24
Next Year17.30%N/AN/A0.27
Next 5 Years (per annum)97.20%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A